Picture of Healios KK logo

4593 — Healios KK News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Healios KK Says Announcement Of iPSC Derived Gene-Modified NK Cell Development Targeting Solid Tumors

Jan 10 (Reuters) - Healios KK  4593.T :
    * HEALIOS KK - ANNOUNCEMENT OF IPSC DERIVED GENE-MODIFIED NK
CELL
DEVELOPMENT TARGETING SOLID TUMORS
    * HEALIOS KK - DECIDED TO ADD DEVELOPMENT OF ALLOGENEIC, IPS
CELL
DERIVED GENE-MODIFIED NATURAL KILLER CELLS TO CO'S PIPELINE

Source text for Eikon:  ID:nPn8dd5C6a 
Further company coverage:  4593.T 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Healios KK

See all news